Given the known role of the EGFR in pathologies such as cancer and auto-immune diseases [45,46,47], the physiological and translational significance of our findings is that they provide new insights into how the processing and functional activation of EGFR-ligands by ADAM17 may be regulated. The gene discussed is ADAM17; the disease is cancer.